These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Poor solubility and stability of rapamycin in aqueous environments. van der Wagt MAJ; Touw DJ; Dekkers BGJ Biomed Pharmacother; 2024 Jul; 176():116865. PubMed ID: 38850655 [No Abstract] [Full Text] [Related]
4. A Curvilinear-Path Umbrella Sampling Approach to Characterizing the Interactions Between Rapamycin and Three FKBP12 Variants. Joshi DC; Gosse C; Huang SY; Lin JH Front Mol Biosci; 2022; 9():879000. PubMed ID: 35874613 [TBL] [Abstract][Full Text] [Related]
5. Rational design of a ligand-controlled protein conformational switch. Dagliyan O; Shirvanyants D; Karginov AV; Ding F; Fee L; Chandrasekaran SN; Freisinger CM; Smolen GA; Huttenlocher A; Hahn KM; Dokholyan NV Proc Natl Acad Sci U S A; 2013 Apr; 110(17):6800-4. PubMed ID: 23569285 [TBL] [Abstract][Full Text] [Related]
6. Combination antifungal therapy involving amphotericin B, rapamycin and 5-fluorocytosine using PEG-phospholipid micelles. Vakil R; Knilans K; Andes D; Kwon GS Pharm Res; 2008 Sep; 25(9):2056-64. PubMed ID: 18415047 [TBL] [Abstract][Full Text] [Related]
7. In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus. Steinbach WJ; Schell WA; Blankenship JR; Onyewu C; Heitman J; Perfect JR Antimicrob Agents Chemother; 2004 May; 48(5):1664-9. PubMed ID: 15105118 [TBL] [Abstract][Full Text] [Related]
8. Rapamycin and less immunosuppressive analogs are toxic to Candida albicans and Cryptococcus neoformans via FKBP12-dependent inhibition of TOR. Cruz MC; Goldstein AL; Blankenship J; Del Poeta M; Perfect JR; McCusker JH; Bennani YL; Cardenas ME; Heitman J Antimicrob Agents Chemother; 2001 Nov; 45(11):3162-70. PubMed ID: 11600372 [TBL] [Abstract][Full Text] [Related]
9. Protein translocation as a tool: The current rapamycin story. Putyrski M; Schultz C FEBS Lett; 2012 Jul; 586(15):2097-105. PubMed ID: 22584056 [TBL] [Abstract][Full Text] [Related]
10. Antifungal rapamycin analogues with reduced immunosuppressive activity. Dickman DA; Ding H; Li Q; Nilius AM; Balli DJ; Ballaron SJ; Trevillyan JM; Smith ML; Seif LS; Kim K; Sarthy A; Goldman RC; Plattner JJ; Bennani YL Bioorg Med Chem Lett; 2000 Jul; 10(13):1405-8. PubMed ID: 10888319 [TBL] [Abstract][Full Text] [Related]
11. Rapamycin: something old, something new, sometimes borrowed and now renewed. Hartford CM; Ratain MJ Clin Pharmacol Ther; 2007 Oct; 82(4):381-8. PubMed ID: 17728765 [TBL] [Abstract][Full Text] [Related]
12. Antifungal activities of rapamycin and its derivatives, prolylrapamycin, 32-desmethylrapamycin, and 32-desmethoxyrapamycin. Wong GK; Griffith S; Kojima I; Demain AL J Antibiot (Tokyo); 1998 May; 51(5):487-91. PubMed ID: 9666177 [TBL] [Abstract][Full Text] [Related]